UofG Cancer Sciences
@UofGCancerSci
News from the School of Cancer Sciences @UofGlasgow @POG_LRC @CRUK_SI Follow our @SCS_AthenaSWAN V.O.I.C.E. Committee π§¬
ID:2587990673
https://www.gla.ac.uk/schools/cancersciences/ 06-06-2014 21:04:20
3,8K Tweets
2,1K Followers
619 Following
Follow People
The first invited talk of the afternoon is from Owen Sansom π³οΈβπ of CRUK Scotland Inst UofG Cancer Sciences University of Glasgow on Wnt pathway mutations in colon and liver cancer.
#WntUK2024
In-depth discussions with professionals in the field, a fully enjoyable experience, thanks for Alex Tonks and his PhD Alanazi π¬π¬π¬
Fully immersed in #BSH2024 in Liverpool. Ready for poster session this evening (PO15), plenty still to hear about before then. Good luck Jessica, our representative PGR from POG Research UofG Cancer Sciences
We are back! βοΈ
We were in San Diego at AACR presenting our work and enjoying everyone elseβs!
Kathryn A F Pennel presented her work on therapeutic biomarkers in colorectal cancer, while Gerard Lynch represented INCISE with a poster on predictive biomarkers!
Wonderful PhD opportunity in Glasgow with a brilliant supervisor and a great team. Intriguing topic tooβ¦RadNetCRUKGlasgow UofG Cancer Sciences Cancer Research UK in Scotland
Join us to explore how radiotherapy affect metastasis in pancreatic cancer in this fantastic opportunity at the CRUK Scotland Centre β¬οΈβ¬οΈ
@CRUKSI UofG Cancer Sciences
findaphd.com/phds/project/fβ¦
We were delighted to welcome Alex Tonks (Cardiff) to Glasgow, who presented the Tessa Holyoake Memorial lecture this lunchtime with POG Research in attendance and colleagues from UofG Cancer Sciences. Great to learn about new therapeutic directions in AML. Thanks Alex!
Looking forward to speaking about our 3D in vitro model of #glioblastoma at this launch of the NC3Rs Oncology Network.
Recently refined for medium throughput evaluation of #RTdrugcombo with clonogenic survival as readout
rb.gy/kr44y1
#3Dtrumps2D
Register now for our Oncology Network launch to accelerate adoption of 3Rs approaches across the research community. The meeting agenda is now live. Chaired by Prof Owen Sansom it includes a keynote talk from Anthony Chalmers π.
ποΈ 20 May 2024
nc3rs.org.uk/events/oncologβ¦
Check out this piece from PREDICT-Meso co-I Daniel J. Murphy on the importance of of Genetically Engineered Mouse Models (GEMM) π and how they support #CancerResearch
#Mesothelioma GEMM are vital to #PREDICTMeso WP3 & WP4 and our aims to discover better mesothelioma treatments
The April2024 PREDICT-Meso Newsletter is now live
sway.cloud.microsoft/23cXERCrgbw1ANβ¦
This edition features updates on work packages, a new exciting collaboration & photos of our PREDICT-Meso visit to Scottish Parliament
#mesothelioma #MesotheliomaResearch #PREDICTMeso #PREDICTMeso Newsletter
I you would like to apply through this fellowship to come join our team CRUK Scotland Inst looking at metastasis in colorectal cancer, get in touch!
π£ Just 2 days left to register for the IPSCC! π£
Join us for enlightening talks from leading experts in the field. Seize this opportunity to connect and learn! Register now! #IPSCC #BerlinConference #MDC #CancerResearch
ipscconference.org
In a session on novel agents & emerging therapeutic strategies at #AACR24 , Jonathan Yang (Memorial Sloan Kettering Cancer Center) presents data on the safety & efficacy of AZD1390 + radiation therapy for #Glioblastoma , co-authored by Anthony Chalmers π (@UofGlasgow): bit.ly/3Pxjony
UofG MVLS
Jonathan Yang presents our phase I data:
AZD1390 very well tolerated in combination with #radiotherapy for #glioblastoma
Promising survival (>12 months) in recurrent GBM
Survival data for newly diagnosed patients maturing
Very excited about this RT-ATM inhibitor combination! #btsm